• Abhishikta Chakraborty
• Bijal Zaveri

Counterfeit medicines pose a significant threat to public health in India. These are contributing to thousands of deaths and substantial economic losses. This study analyzes counterfeit drug prevalence using data from WHO, CDSCO and major case studies across India. Statistical analysis and trend visualizations reveal a rise in spurious drugs, online pharmacy cases and regulatory actions between 2020-2024. Findings indicate strong correlations between fake drugs, regulatory enforcement and economic impact. Blockchain tracking, AI-powered drug authentication and stricter enforcement are essential to combat this crisis. Collaborative efforts between the government, pharmaceutical industry and technology sectors are needed. This is to safeguard the pharmaceutical supply chain and restore consumer trust. Future research should focus on AI-driven counterfeit detection and blockchain-based tracking systems. This will help to enhance drug safety in India.

Counterfeit medicines, pharmaceutical regulation, AI drug detection, blockchain tracking, drug safety

"Analyzing The Extent of Fake Medicines in The Indian Market: Scale, Impact and Solutions", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 3, page no.i673-i676, March-2025, Available :http://www.jetir.org/papers/JETIR2503890.pdf

"Analyzing The Extent of Fake Medicines in The Indian Market: Scale, Impact and Solutions", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 3, page no. ppi673-i676, March-2025, Available at : http://www.jetir.org/papers/JETIR2503890.pdf